Senior Scientist, Bioconjugation & Targeted Nanomedicine

Role: Senior Scientist in Bioconjugation & Targeted Nanomedicine within BMS's Non-Viral Delivery team, focusing on engineering molecular interfaces for targeted nanoparticle delivery systems. Responsibilities include designing and optimizing bioconjugation strategies for diverse ligand formats (antibodies, peptides), developing analytical workflows for conjugate characterization, and integrating targeting ligands into nanoparticle platforms to enhance delivery to specific cell types and tissues. The role involves cross-functional collaboration with protein engineering, formulation, analytical, immunology, and pharmacology teams, with a focus on translating molecular design into functional delivery systems. Requirements: PhD in Organic Chemistry, Bioengineering, Pharmaceutical Sciences, or related fields with 2+ years industry or academic experience; expertise in bioconjugation chemistry, linker strategies, and bioconjugate analytical methods (LC-MS, HPLC, SEC, etc.). Preferred qualifications include experience with nanoparticle-based delivery systems, antibody or peptide conjugates, and advanced analytical techniques. High-value specifics: focus on next-generation, engineered targeted nanomedicines for hematologic malignancies, solid cancers, and autoimmune diseases; emphasis on molecular design and conjugate chemistry; and a collaborative research environment. The position is based in Cambridge, MA, with an emphasis on innovative, translational research in cellular and molecular therapeutics.